World’s second malaria vaccine gets WHO approval: Serum Institute of India
PTI, Oct 3, 2023, 9:31 AM IST
Representative image (Source: Pexels)
New Delhi: Serum Institute of India on Monday said the World Health Organisation (WHO) has approved a malaria vaccine, paving the way for the global roll-out of the world’s second such vaccine.
The recommendation is based on pre-clinical and clinical trial data which showed good safety and high efficacy in four countries, at sites with both seasonal and perennial malaria transmission, making it the world’s second-ever WHO recommended vaccine for preventing malaria in children, SII said in a statement.
The R21/Matrix-M malaria vaccine developed by the University of Oxford and the Serum Institute of India (SII), leveraging Novavax’s adjuvant technology, has been recommended for use by the WHO.
The vaccine is licensed to the Pune-based SII and the company has already established production capacity for 100 million doses per annum, which will be doubled over the next two years, it added.
“For far too long, malaria has threatened the lives of billions of people across the globe, disproportionately affecting the most vulnerable amongst us,” SII CEO Adar Poonawalla noted.
This is why the WHO recommendation and approval of the vaccine marks a huge milestone in fighting Malaria, he added.
With the approval and recommendations by the WHO, additional regulatory approvals are expected to follow shortly and R21/Matrix-M vaccine doses could be ready to begin wider roll-out as early as next year, SII stated.
Currently, the vaccine has been licensed for use in Ghana, Nigeria and Burkina Faso.
The vaccine was developed by the Jenner Institute at Oxford University and SII with support from the European and Developing Countries Clinical Trials Partnership (EDCTP), the Wellcome Trust, and the European Investment Bank (EIB).
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Adani-Hindenburg row: Public Accounts Committee calls SEBI chief on Oct 24
RBI research says onion farmers get 36% of consumers’ spend, pitches for futures trading, private mandis
Markets fall in early trade on unabated foreign fund outflows, Middle East conflict
BSE to discontinue weekly index derivatives on Sensex 50, Bankex following SEBI’s directive
Sensex, Nifty slump in early trade as Middle East conflict deepens
MUST WATCH
Latest Additions
Satark Park: Dedicated to unsung heroes of military intelligence comes up in Pune
Uttarakhand: Two stranded foreign mountaineers safely rescued after three-day ordeal
Junior doctors, protesting RG Kar horror, begin fast unto death ahead of Durga Puja
Over 52,000 nominations received for ‘sarpanch’ posts for panchayat polls in Punjab
22 booked for duping Thane bank of Rs 39 lakh by mortgaging fake jewellery
Thanks for visiting Udayavani
You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.